Signup Crypto ETF Stocks News

Priority Income Fund Announces Intent to Seek Public Listing of Shares of Common Stock

NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Priority Income Fund, Inc. ( "Priority Income Fund" or the "Fund" ) is pleased to announce today that the Fund intends to seek to list shares of its common stock on a national securities exchange, with a target listing date during the next twelve ...

Source: www.benzinga.com
April 25, 2025 | 18:09:19
Category: General

T-Mobile Beats Estimates, But Customer Growth Leaves Investors Wanting More, Says Analyst - Comcast ( NASDAQ:CMCSA ) , AT&T ( NYSE:T )

T-Mobile stock dips despite solid Q1 as postpaid adds, guidance updates fall short of bullish investor hopes. Analyst still bullish on T-Mobile, citing strong broadband growth and healthy wireless market despite industry slowdown. Feel unsure about the market's next move?

Source: www.benzinga.com
April 25, 2025 | 18:09:27
Category: Trading

Oil Drops Below Key Support: Is $55 The Next Stop For West Texas Intermediate? - United States Oil Fund ( ARCA:USO )

Oil breaks key support at $64, signaling further downside risk, with $55-$56 as the next support level. USO ETF mirrors oil's decline, with technical indicators signaling a bearish outlook ahead. Today's manic market swings are creating the perfect setup for Matt's next volatility trade.

Source: www.benzinga.com
April 25, 2025 | 18:09:48
Category: Trading

GameStop Stakeholders Are Not Aligned on Bitcoin Strategy: Strive CEO

When will GameStop buy Bitcoin after raising $1.5 billion for the move? Strive CEO Matt Cole says there's still internal debate.

Source: decrypt.co
April 25, 2025 | 18:12:25
Category: News

PepsiCo Posts In-Line Results As Guidance Reflects Tariff Costs, Analysts Say - PepsiCo ( NASDAQ:PEP )

The company's 2025 guidance reflects tariff costs. Today's manic market swings are creating the perfect setup for Matt's next volatility trade. Get his next trade alert for free, right here. Shares of PepsiCo Inc. PEP tanked after the company reported a sales decline for the first quarter on ...

Source: www.benzinga.com
April 25, 2025 | 18:12:47
Category: Trading

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX - Pliant Therapeutics ( NASDAQ:PLRX )

NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc ( "Pliant" or the "Company" ) PLRX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Source: www.benzinga.com
April 25, 2025 | 16:01:55
Category: News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flywire Corporation - FLYW - Flywire ( NASDAQ:FLYW )

NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Flywire Corporation ( "Flywire" or the "Company" ) FLYW. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Source: www.benzinga.com
April 25, 2025 | 16:02:06
Category: News

Approval of Convertible Loan Note Amendments

Global InterConnection Group announces the Approval of Convertible Loan Note Amendments following Agreement of the Atlantic SuperConnection Spin-Out and Supporting Right of First Refusal Process. Please see the full press release attached. • Right of First Refusal for CLN investment

Source: www.globenewswire.com
April 25, 2025 | 16:03:00
Category: News

Why Tesla Stock Is Soaring Today

Shares of Tesla ( NASDAQ: TSLA ) are climbing on Friday. The electric vehicle ( EV ) maker's stock had gained 8.7% as of noon ET. The rise comes as the S&P 500 was mostly flat and the Nasdaq Composite rose modestly.What's fueling the optimism?

Source: www.fool.com
April 25, 2025 | 16:04:00
Category: News

Autolus Therapeutics Announces License of AUCATZYL® ( obecabtagene autoleucel ) Issued by UK MHRA for Adult Patients ( ≥ 18 years ) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia ( R/R B-ALL ) ( 1 )

Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory ...

Source: www.globenewswire.com
April 25, 2025 | 16:06:00
Category: News

© Natavest 2025 - 2026